Vaccinations

Finance

New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why

Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source

Read More
Finance

Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy

Cash-strapped Covid vaccine Novavax still faces a nunber of challenges, chiefly competing with Pfizer and Moderna in the U.S. commercial

Read More
Finance

FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns

The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus

Read More
Finance

FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus

The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that

Read More
Finance

FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults

The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential

Read More
Finance

‘Once-in-a-generation’ prescription drug pricing reform could be coming. Here’s what we know

A Democratic bill calls for letting Medicare negotiate the price of prescription drugs. The change may result in significant savings

Read More